Variable | All patients (n = 278) | MACE + (n = 52) | MACE – (n = 226) | P value |
---|---|---|---|---|
Age, years | 65 (55–73) | 69 (60–77) | 64 (55–72) | 0.02 |
Male sex, n (%) | 201 (72.3) | 36 (69.2) | 164 (72.9) | 0.27 |
Hypertension, n (%) | 190 (68.6) | 39 (75.0) | 224 (67.0) | 0.29 |
Diabetes mellitus, n (%) | 74 (26.7) | 21 (40.4) | 53 (23.7) | 0.04 |
Hyperlipidemia, n (%) | 88 (31.8) | 21 (40.4) | 66 (29.5) | 0.20 |
Current smoking, n (%) | 104 (37.5) | 14 (26.9) | 89 (39.7) | 0.17 |
Serum creatinine, μmol/l | 80 (68–91) | 83 (69–99) | 79 (68–90) | 0.18 |
BMI, kg/m2 | 27 (25–30) | 27 (26–30) | 27 (25–30) | 0.80 |
CK-MBmax, μmol/l | 3.0 (1.4–5.2) | 4.5 (1.6–6.7) | 2.8 (1.6–5.0) | <0.001 |
TIMI-risk score | 3.0 (2.0–5.0) | 5.0 (3.0–7.0) | 3.0 (2.0–5.0) | <0.001 |
ST-segment resolution, % | 73 (50–100) | 62 (32–77) | 76 (50–100) | 0.003 |
Angiographic findings, n (%) | Â | Â | Â | Â |
TIMI-flow pre-PCI 0 | 147 (52.8) | 33 (63.4) | 115 (50.9) | 0.03 |
TIMI-flow pre-PCI I-III | 131 (47.1) | 19 (36.5) | 111 (49.1) | Â |
TIMI-flow post-PCI 0-II | 36 (12.9) | 39 (75.0) | 23 (10.6) | 0.002 |
TIMI-flow post-PCI III | 242 (87.0) | 13 (25.0) | 203 (89.8) | Â |
LV-EFecho, % | 45 (40–50) | 40 (32–50) | 46 (40–55) | 0.001 |
Time-to-revascularization, min | 193 (132–348) | 211 (135–396) | 190 (128–336) | 0.35 |
CMR parameters | Â | Â | Â | Â |
LV-EFCMR, % | 52 (42–60) | 41 (33–50) | 54 (45–62) | <0.001 |
Infarct size, %LV | 16.1 (8.2–26.6) | 31.5 (22.5–40.0) | 13.1 (5.7–22.4) | <0.001 |
MO, %LV | 0.69 (0.1–1.6) | 1.5 (0.6–2.9) | 0.6 (0.0–1.5) | 0.001 |
MSI | 48.0 (27.3–73.5) | 27.0 (10.0–;39.7) | 67.4 (47.9–83.3) | <0.001 |